FDA Adverse Event Injury Summary report: N

TANDEM RX CANNULA

MDR report key: 1413952 · Received July 14, 2009

Report

Report Number
3005099803-2009-03307
Event Type
Injury
Date Received
July 14, 2009
Date of Event
June 17, 2009
Report Date
June 19, 2009
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NML
PMA / PMN Number
K970054
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE LOT NUMBER; THEREFORE, THE DEVICE MANUFACTURE AND EXPIRATION DATES ARE UNKNOWN. THE DEVICE HAS BEEN RECEIVED BY THIS MANUFACTURER, HOWEVER, THE INVESTIGATION HAS NOT YET BEEN PERFORMED. UPON COMPLETION OF THE FAILURE ANALYSIS OF THE COMPLAINT DEVICE, IF THERE IS ANY FURTHER RELEVANT INFO FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORP ON 06/19/2009, THAT A TANDEM REX CANNULA WAS USED DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE IN 2009. ACCORDING TO THE COMPLAINANT, AN ERCP WAS COMPLETED WITH THIS DEVICE. A LITHOTRIPSY PROCEDURE WAS THEN PERFORMED WITH ANOTHER DEVICE AND A RETRIEVAL BALLOON. FOLLOWING THE LITHOTRIPSY, A CONTRAST TEST WAS CONDUCTED AND IT WAS NOTICED THAT RO MARKER OF THE CANNULA REMAINED IN THE BILE DUCT. THE PHYSICIAN INDICATED HE WAS CONCERNED THAT THE RO MARKER REMAINED IN THE DUCT. HOWEVER, THE PROCEDURE WAS COMPLETED AT THAT TIME. ANOTHER PROCEDURE WAS RESCHEDULED FOR ONE WEEK LATER, FOR RETRIEVAL OF THE MARKER. ON THAT DAY, THE PT UNDERWENT A CONTRAST TEST. THE RO MARKER WAS NOT FOUND. THE PHYSICIAN INDICATED THAT THE RO MARKER HAD MOST LIKELY BEEN ELIMINATED VIA NORMAL PERISTALSIS. THE PT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE GOOD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TANDEM RX CANNULA NML BOSTON SCIENTIFIC CORPORATION M00545820 UNK

Patients

Seq Age Sex Outcome Treatment
1 64 YR Other